Collectively, our data support a model whereby melatonin upregulates the expression of BMAL1, which is associated with ALDH3A1, thereby affecting the glycolytic process and ultimately influencing the proliferation of breast cancer cells. This evidence concerns the gene ALDH3A1 and breast carcinoma.